Back to top

Abivax price target raised to $155 from $135 at Truist

Truist raised the firm’s price target on Abivax (ABVX) to $155 from $135 and keeps a Buy rating on the shares. ollowing maintenance Part 2 data, di...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Abivax SA Sponsored ADR (ABVX)